Updates and news related to prostate cancer:
Stereotactic body radiotherapy produced similar efficacy without added toxicity compared with standard radiation in men with advanced prostate cancer.
Thomas Jefferson University: An Unexpected, & Novel, Target for Prostate Cancer – Our Biological Clock
Studies have shown that when circadian rhythms are disturbed through sleep deprivation, jet lag, or shift work, there is an increased incidence of some cancers including prostate cancer, which is the second leading cause of cancer death for men in the U.S.
A Mediterranean diet is non-invasive, good for overall health and, as shown by this study, has the potential to affect the progression of the cancer.
In this video, Christopher Sweeney joins Charles Ryan to discuss the topic of hormone-sensitive prostate cancer, specifically concentrating on how clinicians can confront and categorize their patients with the disease.
What's the connection?
Watch this video from Oncology Today with Dr. Neil Love: on the role of PARP inhibition in the management of prostate cancer.
The test seems likely to improve the diagnosis and treatment of a disease that kills 33,000 American men each year.
In Groundbreaking Move, FDA Approves Myovant’s Relugolix as the First Once-a-Day Pill for Advanced Prostate Cancer
It’s the first oral hormone therapy approved for the indication, regulators said, and the drug will be marketed as Orgovyx.
Olaparib has "ushered in the era of precision medicine in prostate cancer," said Maha Hussain, MD, quoted in Urology Times.
PSMA PET/CT is an obvious challenger to conventional imaging.